-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Estrella Immunopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2022 to Q3 2024.
- Estrella Immunopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
- Estrella Immunopharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.19M, a 192% increase from 2023.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)